- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: vesicare
Total 85 results
-
Advanced Research NetworkAstellas Pharma US, Inc.TerminatedOver-Active BladderUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)Germany
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Czech Republic, Poland, Hungary, Belgium, Germany
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)Germany
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOver Active BladderKorea, Republic of
-
Asan Medical CenterSamsung Medical Center; Seoul National University Hospital; Cheil General Hospital... and other collaboratorsCompletedOveractive BladderKorea, Republic of
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Bay State Clinical Trials, Inc.TerminatedOveractive BladderUnited States
-
University of California, IrvineAstellas Pharma US, Inc.CompletedUrinary IncontinenceUnited States
-
Astellas Pharma Europe B.V.Veeda Clinical ResearchCompletedLower Urinary Tract Predominant Storage SymptomsBelgium
-
Astellas Pharma Europe B.V.Completed
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedOveractive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic HypertrophyJapan
-
University of South FloridaWithdrawnUrinary Incontinence | Parkinson's DiseaseUnited States
-
Barrie Urology AssociatesAstellas Pharma Canada, Inc.CompletedUrinary Bladder, OveractiveCanada
-
Barrie Urology AssociatesAstellas Pharma Canada, Inc.CompletedUrinary Bladder, Overactive | Flank PainCanada
-
University of Alabama at BirminghamAstellas Pharma IncCompletedUrethral Sphincter ActivityUnited States
-
Rambam Health Care CampusUnknownUrinary Bladder, OveractiveIsrael
-
Hartford HospitalAstellas Pharma IncTerminatedPelvic Organ ProlapseUnited States
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOveractive Bladder | Urinary Bladder, OveractiveKorea, Republic of
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin SuccinateUnited States
-
Astellas Pharma IncAstellas Pharma Indonesia Inc.CompletedOveractive BladderIndonesia
-
University of California, IrvineAstellas Pharma IncTerminatedIncontinenceUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Completed
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin Succinate | Bioavailability of Solifenacin SuccinateUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina